• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估具有膦肽缀合物的稳定铜(I)配合物的体外抗癌活性。

Evaluation of anticancer activity in vitro of a stable copper(I) complex with phosphine-peptide conjugate.

机构信息

Faculty of Chemistry, University of Wroclaw, Joliot-Curie 14, 50-383, Wroclaw, Poland.

Małopolska Center of Biotechnology, Jagiellonian University, Gronostajowa 7A, 30-387, Kraków, Poland.

出版信息

Sci Rep. 2021 Dec 14;11(1):23943. doi: 10.1038/s41598-021-03352-2.

DOI:10.1038/s41598-021-03352-2
PMID:34907288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8671550/
Abstract

[CuI(2,9-dimethyl-1,10-phenanthroline)P(p-OCH-Ph)CHSarcosineGlycine] (1-MPSG), highly stable in physiological media phosphino copper(I) complex-is proposed herein as a viable alternative to anticancer platinum-based drugs. It is noteworthy that, 1-MPSG significantly and selectively reduced cell viability in a 3D spheroidal model of human lung adenocarcinoma (A549), in comparison with non-cancerous HaCaT cells. Confocal microscopy and an ICP-MS analysis showed that 1-MPSG effectively accumulates inside A549 cells with colocalization in mitochondria and nuclei. A precise cytometric analysis revealed a predominance of apoptosis over the other types of cell death. In the case of HaCaT cells, the overall cytotoxicity was significantly lower, indicating the selective activity of 1-MPSG towards cancer cells. Apoptosis also manifested itself in a decrease in mitochondrial membrane potential along with the activation of caspases-3/9. Moreover, the caspase inhibitor (Z-VAD-FMK) pretreatment led to decreased level of apoptosis (more pronouncedly in A549 cells than in non-cancerous HaCaT cells) and further validated the caspases dependence in 1-MPSG-induced apoptosis. Furthermore, the 1-MPSG complex presumably induces the changes in the cell cycle leading to G2/M phase arrest in a dose-dependent manner. It was also observed that the 1-MPSG mediated intracellular ROS alterations in A549 and HaCaT cells. These results, proved by fluorescence spectroscopy, and flow cytometry, suggest that investigated Cu(I) compound may trigger apoptosis also through ROS generation.

摘要

[CuI(2,9-二甲基-1,10-菲咯啉)P(p-OCH-Ph)CHSarcosineGlycine](1-MPSG),在生理介质中具有高度稳定性的膦铜(I)配合物,被提出作为抗癌铂类药物的可行替代品。值得注意的是,与非癌细胞 HaCaT 相比,1-MPSG 在人肺腺癌细胞(A549)的 3D 球体模型中显著且选择性地降低了细胞活力。共焦显微镜和 ICP-MS 分析表明,1-MPSG 有效地在 A549 细胞内积累,与线粒体和细胞核共定位。精确的细胞计量分析显示,细胞凋亡占主导地位,而其他类型的细胞死亡则较少。在 HaCaT 细胞中,整体细胞毒性明显较低,表明 1-MPSG 对癌细胞具有选择性活性。细胞凋亡还表现为线粒体膜电位降低,同时激活 caspase-3/9。此外,用 caspase 抑制剂(Z-VAD-FMK)预处理会导致凋亡水平降低(在 A549 细胞中比在非癌细胞 HaCaT 细胞中更为明显),进一步验证了 caspase 在 1-MPSG 诱导的凋亡中的依赖性。此外,1-MPSG 配合物可能会导致细胞周期发生变化,以剂量依赖的方式导致 G2/M 期阻滞。还观察到 1-MPSG 介导的 A549 和 HaCaT 细胞内 ROS 改变。这些结果通过荧光光谱法和流式细胞术证明,表明所研究的 Cu(I)化合物可能通过 ROS 生成引发细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/8703b8a333bb/41598_2021_3352_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/13b2ddb80b86/41598_2021_3352_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/9a1298c0a7fb/41598_2021_3352_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/bb9d1d4fe1e8/41598_2021_3352_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/744d3f2e52ed/41598_2021_3352_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/447c15fcedca/41598_2021_3352_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/8583abd2d603/41598_2021_3352_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/f5617552759a/41598_2021_3352_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/d91d729e0093/41598_2021_3352_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/2640815c706b/41598_2021_3352_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/f87b205215c8/41598_2021_3352_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/8703b8a333bb/41598_2021_3352_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/13b2ddb80b86/41598_2021_3352_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/9a1298c0a7fb/41598_2021_3352_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/bb9d1d4fe1e8/41598_2021_3352_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/744d3f2e52ed/41598_2021_3352_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/447c15fcedca/41598_2021_3352_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/8583abd2d603/41598_2021_3352_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/f5617552759a/41598_2021_3352_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/d91d729e0093/41598_2021_3352_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/2640815c706b/41598_2021_3352_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/f87b205215c8/41598_2021_3352_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b8/8671550/8703b8a333bb/41598_2021_3352_Fig11_HTML.jpg

相似文献

1
Evaluation of anticancer activity in vitro of a stable copper(I) complex with phosphine-peptide conjugate.评估具有膦肽缀合物的稳定铜(I)配合物的体外抗癌活性。
Sci Rep. 2021 Dec 14;11(1):23943. doi: 10.1038/s41598-021-03352-2.
2
Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action.含膦肽(SarGly)共轭物的选择性 Cu(I) 配合物抗乳腺癌:合成、光谱表征及细胞毒作用研究。
J Inorg Biochem. 2018 Sep;186:162-175. doi: 10.1016/j.jinorgbio.2018.06.009. Epub 2018 Jun 18.
3
Copper(I) complexes with phosphines P(p-OCH-Ph)CHOH and P(p-OCH-Ph)CHSarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity.铜(I)配合物与膦 P(p-OCH-Ph)CHOH 和 P(p-OCH-Ph)CHSarGly。合成、多模态 DNA 相互作用以及促氧化和体外抗增殖活性。
J Inorg Biochem. 2020 Feb;203:110926. doi: 10.1016/j.jinorgbio.2019.110926. Epub 2019 Nov 15.
4
Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu/Cu redox, DNA binding and cleavage, cytotoxicity and apoptosis-inducing ability.三乙烯四胺八面体铜(II)-二亚胺配合物:立体化学动态和配体疏水性对 Cu/Cu 氧化还原、DNA 结合和切割、细胞毒性和诱导细胞凋亡能力的影响。
Dalton Trans. 2020 Jun 23;49(24):8282-8297. doi: 10.1039/d0dt00928h.
5
Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).蒽-9-咪唑啉腙(9-AIH)铜(II)配合物的合成及其抗肿瘤机制
Metallomics. 2015 Jul;7(7):1124-36. doi: 10.1039/c5mt00027k.
6
Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.含苯基和环己基的叔膦配合的 saccharinate 铂(II)配合物的合成、结构及针对线粒体和 DNA 的抗癌活性。
Eur J Med Chem. 2018 Jul 15;155:609-622. doi: 10.1016/j.ejmech.2018.06.035. Epub 2018 Jun 17.
7
Cu and Cu complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action.铜和铜配合物与氟喹诺酮类抗生素的膦衍生物 - 细胞毒性作用模式的比较研究。
J Inorg Biochem. 2018 Apr;181:1-10. doi: 10.1016/j.jinorgbio.2018.01.008. Epub 2018 Jan 9.
8
Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.两种双核 Cu(II) 配合物通过包含碳酰腙配体和 1,10-邻菲啰啉作为共配体,对 DNA 的高效水解断裂作用以及对人癌细胞的抗增殖作用。
J Biol Inorg Chem. 2019 May;24(3):343-363. doi: 10.1007/s00775-019-01651-8. Epub 2019 Mar 18.
9
Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.四种钌多吡啶配合物作为抗肿瘤药物的研发:设计、生物学评价及作用机制研究
J Inorg Biochem. 2020 Jul;208:111104. doi: 10.1016/j.jinorgbio.2020.111104. Epub 2020 May 19.
10
Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity.铜(I)-膦多吡啶配合物:合成、表征、DNA/人血清白蛋白结合研究及抗增殖活性
Inorg Chem. 2017 Apr 3;56(7):3781-3793. doi: 10.1021/acs.inorgchem.6b02419. Epub 2017 Mar 14.

引用本文的文献

1
Bilosomal Encapsulation of Binuclear Phosphino Ru(II)-Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers.双核膦基钌(II)-铜(II)化合物的脂质体包封增强了它们对肺癌和前列腺癌的选择性和活性。
J Med Chem. 2025 Jul 24;68(14):14442-14464. doi: 10.1021/acs.jmedchem.5c00486. Epub 2025 Jul 9.
2
Innovative Approaches in the Synthesis and Optimization of Copper Complexes for Antitumor Therapies: A Comprehensive Review.用于抗肿瘤治疗的铜配合物合成与优化的创新方法:综述
Molecules. 2025 May 9;30(10):2104. doi: 10.3390/molecules30102104.
3
-[Pt(amine)Cl(PPh)] Complexes Target Mitochondria and Endoplasmic Reticulum in Gastric Cancer Cells.

本文引用的文献

1
Anti-proliferative, pro-apoptotic and anti-invasive effect of the copper coordination compound Cas III-La through the induction of reactive oxygen species and regulation of Wnt/β-catenin pathway in glioma.铜配位化合物Cas III-La通过诱导活性氧和调节胶质瘤中的Wnt/β-连环蛋白通路产生抗增殖、促凋亡和抗侵袭作用。
J Cancer. 2021 Jul 25;12(19):5693-5711. doi: 10.7150/jca.59769. eCollection 2021.
2
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.作为靶向拓扑异构酶I和II的抗癌剂的铜配合物
Cancers (Basel). 2020 Oct 5;12(10):2863. doi: 10.3390/cancers12102863.
3
We need to talk about the Warburg effect.
[Pt(胺)Cl(PPh)] 配合物靶向胃癌细胞中的线粒体和内质网。
Int J Mol Sci. 2024 Jul 15;25(14):7739. doi: 10.3390/ijms25147739.
4
ROS-producing nanomaterial engineered from Cu(I) complexes with PN-ligands for cancer cells treating.由含PN配体的Cu(I)配合物构建的用于癌细胞治疗的产ROS纳米材料。
Discov Nano. 2023 Oct 30;18(1):133. doi: 10.1186/s11671-023-03912-7.
5
Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes.金属药物在对抗非小细胞肺癌中的应用:挖掘改善治疗效果的潜力
Front Pharmacol. 2023 Aug 31;14:1242488. doi: 10.3389/fphar.2023.1242488. eCollection 2023.
6
DYRK1A inhibitors leucettines and TGF-β inhibitor additively stimulate insulin production in beta cells, organoids, and isolated mouse islets.DYRK1A 抑制剂酪丝亮肽和 TGF-β 抑制剂可协同刺激β细胞、类器官和分离的小鼠胰岛中的胰岛素产生。
PLoS One. 2023 May 17;18(5):e0285208. doi: 10.1371/journal.pone.0285208. eCollection 2023.
7
: Synthesis, Physicochemical, and Biological Properties of Phosphino Cu, Ru, Ir Complexes.膦基铜、钌、铱配合物的合成、物理化学性质及生物学性质
Pharmaceuticals (Basel). 2022 Jan 29;15(2):169. doi: 10.3390/ph15020169.
我们需要谈谈瓦伯格效应。
Nat Metab. 2020 Feb;2(2):127-129. doi: 10.1038/s42255-020-0172-2.
4
Amelioration of oxidative stress-mediated apoptosis in copper oxide nanoparticles-induced liver injury in rats by potent antioxidants.强抗氧化剂改善氧化铜纳米颗粒诱导的大鼠肝损伤中的氧化应激介导的细胞凋亡。
Sci Rep. 2020 Jul 2;10(1):10812. doi: 10.1038/s41598-020-67784-y.
5
Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy.线粒体靶向药物及无药制剂用于癌症治疗的最新进展
Cancers (Basel). 2019 Dec 18;12(1):4. doi: 10.3390/cancers12010004.
6
Copper(I) complexes with phosphines P(p-OCH-Ph)CHOH and P(p-OCH-Ph)CHSarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity.铜(I)配合物与膦 P(p-OCH-Ph)CHOH 和 P(p-OCH-Ph)CHSarGly。合成、多模态 DNA 相互作用以及促氧化和体外抗增殖活性。
J Inorg Biochem. 2020 Feb;203:110926. doi: 10.1016/j.jinorgbio.2019.110926. Epub 2019 Nov 15.
7
ROS-mediated lipid peroxidation as a result of Cu(ii) interaction with FomA protein fragments of F. nucleatum: relevance to colorectal carcinogenesis.ROS 介导的脂质过氧化作用是由于 Cu(ii)与 F. nucleatum 的 FomA 蛋白片段相互作用所致:与结直肠肿瘤发生的相关性。
Metallomics. 2019 Dec 11;11(12):2066-2077. doi: 10.1039/c9mt00179d.
8
Mitochondria as multifaceted regulators of cell death.线粒体作为细胞死亡的多面调节者。
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100. doi: 10.1038/s41580-019-0173-8. Epub 2019 Oct 21.
9
Cu(II) Complexes with FomA Protein Fragments of Increase Oxidative Stress and Malondialdehyde Level.Cu(II) 配合物与 FomA 蛋白片段增加氧化应激和丙二醛水平。
Chem Res Toxicol. 2019 Nov 18;32(11):2227-2237. doi: 10.1021/acs.chemrestox.9b00269. Epub 2019 Oct 11.
10
Cinobufagin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis in Malignant Melanoma Cells.华蟾酥毒基诱导恶性黑色素瘤细胞在G2/M期发生细胞周期阻滞并促进其凋亡。
Front Oncol. 2019 Sep 4;9:853. doi: 10.3389/fonc.2019.00853. eCollection 2019.